MIRA Pharmaceuticals, Inc. (MIRA)
NASDAQ: MIRA · Real-Time Price · USD
1.060
+0.060 (6.00%)
At close: Dec 20, 2024, 4:00 PM
1.080
+0.020 (1.89%)
After-hours: Dec 20, 2024, 5:55 PM EST

MIRA Pharmaceuticals Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTM FY 2023 FY 2022 FY 2021 FY 2020
Period Ending
Sep '24 Dec '23 Dec '22 Dec '21 Dec '20
Selling, General & Admin
5.816.954.71.470.16
Research & Development
2.831.572.350.680.04
Operating Expenses
8.648.537.052.150.2
Operating Income
-8.64-8.53-7.05-2.15-0.2
Interest Expense
-2.73-3.46-0.01-0.02-0
Pretax Income
-11.24-11.98-7.06-2.18-0.2
Net Income
-11.24-11.98-7.06-2.18-0.2
Net Income to Common
-11.24-11.98-7.06-2.18-0.2
Shares Outstanding (Basic)
20191813-
Shares Outstanding (Diluted)
20191813-
Shares Change (YoY)
9.59%5.69%38.60%--
EPS (Basic)
-0.57-0.65-0.40-0.17-
EPS (Diluted)
-0.57-0.65-0.40-0.17-
Free Cash Flow
-4.79-4.53-5.6-1.38-0.2
Free Cash Flow Per Share
-0.24-0.24-0.32-0.11-
EBIT
-8.64-8.53-7.05-2.15-0.2
Advertising Expenses
-0.1---
Source: S&P Capital IQ. Standard template. Financial Sources.